Medicare Enrolled

Dr. Grace Wright, MD

Rheumatology · New York, NY
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
345 E 37TH ST, New York, NY 10016
2124906960
In practice since 2006 (19 years)
NPI: 1245240274 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wright from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wright? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wright

Dr. Grace Wright is a rheumatology specialist in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Wright performed 8,525 Medicare services across 723 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wright received a total of $3,167,249 from 47 pharmaceutical and/or device companies across 3170 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wright is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 17% volume in NY $3,167,249 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,525
Medicare services
Top 17% in NY for rheumatology
723
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~449 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 5,460 $18 $33
Joint lubricant injection (Synvisc) 1,008 $7 $50
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
730 $110 $400
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
276 $8 $33
Normal saline infusion, 1000 cc
Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution.
146 $2 $55
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
135 $27 $176
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
130 $60 $303
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
122 $148 $475
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
118 $9 $50
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
98 $58 $440
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
93 $13 $77
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
82 $123 $473
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
34 $82 $350
Bone density scan (DEXA) of forearm, finger, hand, or foot
A DEXA scan measures bone mineral density in the forearm, finger, hand, or foot. This test helps assess bone strength and risk of fracture.
31 $37 $100
Bone density scan (DEXA) of hip, pelvis, and spine
This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures.
30 $60 $660
New patient office visit, complex (60-74 min) 17 $191 $690
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
15 $147 $605
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.8% high complexity
79.5% medium
14.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,167,249
Total received (2018-2024)
Avg $452,464/year across 7 years
Top 0% in NY for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
3,170
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,531,818 (79.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$614,984 (19.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,447 (0.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$343,414
2023
$482,832
2022
$395,466
2021
$452,389
2020
$361,662
2019
$560,192
2018
$571,294

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$169,418
UCB, Inc.
$48,933
Lilly USA, LLC
$37,470
AstraZeneca Pharmaceuticals LP
$30,306
GENZYME CORPORATION
$20,654
E.R. Squibb & Sons, L.L.C.
$19,857
Genentech USA, Inc.
$5,844
Eli Lilly and Company
$4,486
Novartis Pharmaceuticals Corporation
$4,393
Janssen Biotech, Inc.
$1,605
GlaxoSmithKline, LLC.
$88
Mallinckrodt Hospital Products Inc.
$84
Amgen Inc.
$77
Celgene Corporation
$65
Takeda Pharmaceuticals U.S.A., Inc.
$55
ANI Pharmaceuticals, Inc.
$41
PFIZER INC.
$39
Top 3 companies account for 74.5% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$495,311
Lilly USA, LLC
$451,934
ABBVIE INC.
$373,597
UCB, Inc.
$297,288
GENZYME CORPORATION
$249,014
AstraZeneca Pharmaceuticals LP
$212,804
Novartis Pharmaceuticals Corporation
$189,312
E.R. Squibb & Sons, L.L.C.
$168,277
Regeneron Healthcare Solutions, Inc.
$152,621
Amgen Inc.
$115,298
AbbVie, Inc.
$102,334
Eli Lilly and Company
$56,827
PFIZER INC.
$55,096
Novartis Pharma AG
$47,893
Janssen Biotech, Inc.
$46,329
SANOFI-AVENTIS U.S. LLC
$33,980
United Rheumatology
$28,750
Gilead Sciences, Inc.
$18,508
Mallinckrodt LLC
$15,525
Regeneron Pharmaceuticals, Inc.
$14,680
GlaxoSmithKline, LLC.
$12,607
NOVARTIS PHARMACEUTICALS CORPORATION
$10,109
WHITEHALL INTERNATIONAL INC
$6,400
Genentech USA, Inc.
$5,933
UCB SA
$3,162
MEDAC PHARMA, INC.
$669
Mallinckrodt Hospital Products Inc.
$568
Janssen Scientific Affairs, LLC
$345
Aurinia Pharma U.S., Inc.
$312
MEDEXUS PHARMA, INC.
$234
Celgene Corporation
$206
Radius Health, Inc.
$192
Flexion Therapeutics, Inc.
$178
Mallinckrodt Enterprises LLC
$144
Horizon Pharma plc
$132
Actelion Pharmaceuticals US, Inc.
$125
Bioventus LLC
$113
Boehringer Ingelheim Pharmaceuticals, Inc.
$108
DePuy Synthes Sales Inc.
$73
Alexion Pharmaceuticals, Inc.
$68
Takeda Pharmaceuticals U.S.A., Inc.
$55
ANI Pharmaceuticals, Inc.
$41
SOBI, INC
$22
Exeltis, USA Inc.
$20
Abbott Laboratories
$20
Azurity Pharmaceuticals, Inc.
$20
Horizon Therapeutics plc
$18
Top 3 companies account for 41.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIN457A · AIN457F_COSENTYX_IMMUNOLOGY · Actemra · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Durolane · ENBREL · EVENITY · Edarbi · Enbrel · FORTEO · HUMIRA · HYQVIA · Humira · ILARIS · INFLECTRA · JOT DX · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · LUPKYNIS · NO PRODUCT DISCUSSED · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · OPDIVO · ORENCIA · ORTHOVISC · Otezla · PURIFIED CORTROPHIN GEL · Prolia · REMICADE · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Repatha · Rinvoq · Rituxan · SAPHNELO · SECUKINUMAB_COSENTYX_DERMATOLOGY · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · SYNVISC-ONE · Sotyktu · Strensiq · TALTZ · TAVNEOS · TREMFYA · Tymlos · UPTRAVI · XELJANZ · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (80%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for rheumatology in NY.

Looking for a rheumatology specialist in New York?
Compare rheumatologists in the New York area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
385
Per 100K population
23.7
County median income
$104,553
Nearest hospital
BELLEVUE HOSPITAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wright is a mixed practice specialist, with above-average Medicare volume (top 17% in NY), with speaking/promotional industry engagement in the top 0% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wright experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Wright performed 5,460 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wright receive payments from pharmaceutical companies?
Yes. Dr. Wright received a total of $3,167,249 from 47 companies across 3,170 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wright's costs compare to other rheumatologists in New York?
Dr. Wright's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wright) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →